Dianthus Therapeutics (DNTH) Current Assets: 2017-2025
Historic Current Assets for Dianthus Therapeutics (DNTH) over the last 7 years, with Sep 2025 value amounting to $413.8 million.
- Dianthus Therapeutics' Current Assets rose 43.94% to $413.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $413.8 million, marking a year-over-year increase of 43.94%. This contributed to the annual value of $280.9 million for FY2024, which is 58.30% up from last year.
- As of Q3 2025, Dianthus Therapeutics' Current Assets stood at $413.8 million, which was up 56.99% from $263.6 million recorded in Q2 2025.
- Dianthus Therapeutics' Current Assets' 5-year high stood at $413.8 million during Q3 2025, with a 5-year trough of $78.6 million in Q2 2023.
- Moreover, its 3-year median value for Current Assets was $271.0 million (2025), whereas its average is $254.0 million.
- In the last 5 years, Dianthus Therapeutics' Current Assets plummeted by 47.93% in 2023 and then surged by 365.03% in 2024.
- Dianthus Therapeutics' Current Assets (Quarterly) stood at $82.0 million in 2022, then spiked by 116.32% to $177.5 million in 2023, then soared by 58.30% to $280.9 million in 2024, then soared by 43.94% to $413.8 million in 2025.
- Its last three reported values are $413.8 million in Q3 2025, $263.6 million for Q2 2025, and $271.0 million during Q1 2025.